ETFsBloomberg MSCI USD Corporate PAB Green Tilted Index
Amundi

Amundi USD Corporate Bond Climate Paris Aligned UCITS ETF EUR Hedged Dist

USIH PADistributingPhysical, full replicationLuxembourgNot PEA-eligible
Last close · EUR
72.13EUR
+0.26% · +€0.19
Published closes: 29 Oct 2026 - 30 Oct 2026
30 Oct 2026, close
USIHBase
Fund charges
0.20%Total expense ratio (TER)
Fund size
€114.5Mall share classes
Return 1Y
-3.0%
Sharpe 3Y
Not published
Volatility 1Y
4.5%annualised
Holdings
2,279Fund holdings

Performance

Compare
  • USIH-3.0%
  • Price, EUR

Returns

Returns1M3M6MYTD1Y3Y5Y
USIH+1.9%-0.9%-2.0%-3.1%-3.0%+12.0%-11.0%
MSCI World+0.4%+4.9%+10.8%+16.3%+15.9%+75.5%+71.2%
Gap to MSCI World+1.5%-5.7%-12.8%-19.4%-18.9%-63.5%-82.2%

Risk and return

Sharpe ratio · 1Y
-1.00
Below MSCI World · 1.28
Return p.a.
-2.5%
Volatility
4.5%
Max loss
-5.8%Sept 2026

Sharpe vs indices

MSCI World
1.28
S&P 500
1.16
STOXX Europe 600
0.99
MSCI Emerging Markets IMI
0.76
CAC 40
-0.01
USIH
-1.00
Method

Weekly EUR returns from adjusted closes. Sharpe is the annualised excess return over the euro overnight rate (Xtrackers II EUR Overnight Rate Swap UCITS ETF 1C) divided by its volatility. Max loss uses daily closes.

Top holdings

Top 10
2.7%
Holdings
2,279
As of
Fund holdings
  1. 1CVS HEALTH CO 4.3% Mar28US126650CX620.44%
  2. 2BRITISH TEL 9.125% Dec30US111021AE120.31%
  3. 3CIGNA GROUP/T 4.375% Oct28US125523AH380.29%
  4. 4ORACLE CORP 2.95% Apr30US68389XBV640.28%
  5. 5SPRINT CAP CO 8.75% Mar32US852060AT990.25%
  6. 6ABBVIE INC 5.05% Mar34US00287YDU010.23%
  7. 7IBM CORP 3.5% May29US459200KA850.23%
  8. 8ASTRAZENECA P 6.45% Sep37US046353AD010.23%
  9. 9DEUTSCHE TELE 8.75% Jun30US25156PAC770.22%
  10. 10ORACLE CORP 3.25% Nov27US68389XBN490.21%

Countries

Largest
91.7%United States
Top 3
97.2%
Effective number
1.21 / HHI

Market cap

Weight vs holdings

2.7%of the fund sits in the top 10 holdings
  • Holdings 1-10
  • Holdings 11-50
  • Holdings 51-200
  • Holdings 201+

Size split

Not published

Compare ETFs in Copio.

ETF comparison in the Copio app, showing costs and returns with illustrative data.

Factual research, without a suitability score or investment recommendation. Past relationships can change.